TASHA JOSEPH: Open Payments
NPI 1467140046 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,217 in 118 payments from 20 companies in 2025. Trend: 2023 $17 · 2024 $2,036 · 2025 $3,217
Food & beverage: $2,856Education: $361
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $507 |
| Astellas Pharma US Inc | 6 | $453 |
| Sumitomo Pharma America, Inc. | 16 | $309 |
| Boston Scientific Corporation | 5 | $292 |
| UROGEN PHARMA, INC. | 6 | $224 |
| Dendreon Pharmaceuticals LLC | 7 | $176 |
| Blue Earth Diagnostics | 6 | $174 |
| ACCORD HEALTHCARE, INC. | 9 | $167 |
| Telix Pharmaceuticals | 7 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $142 |
Products named: ERLEADA, Xtandi, GEMTESA, PROVENGE, POSLUMA, Camcevi, ILLUCCIX, Axonics.
Industry payments across NV — which companies pay providers there.
